Ikuyama S, Mu Y M, Ohe K, Nakagaki H, Fukushima T, Takayanagi R, Nawata H
Third Department of Internal Medicine, Kyushu University Faculty of Medicine, Fukuoka, Japan.
Clin Endocrinol (Oxf). 1998 May;48(5):647-54. doi: 10.1046/j.1365-2265.1998.00477.x.
An orphan nuclear receptor, DAX-1, is known to be involved in the development and differentiation of anterior pituitary cells. The present study aimed to examine 1) whether DAX-1 is expressed in human pituitary adenomas, and 2) if it is expressed, what types of adenoma express the factor.
Adenoma tissues examined included 18 clinically non-functioning adenomas, 14 GH-secreting adenomas and 7 PRL-secreting adenomas. The expression of the following genes were tested by reverse transcription-polymerase chain reaction (RT-PCR): DAX-1, Adrenal-4-binding protein/steroidogenic factor-1 (Ad4BP/SF-1), Pit-1, LH beta, FSH beta, gonadotrophin-releasing hormone receptor (GnRH-R), GH, PRL, and TSH beta, as well as beta-actin as a control.
Eleven clinically non-functioning adenomas expressed DAX-1, 10 of which also expressed Ad4BP/SF-1. Nine out of the 11 DAX-1 expressing adenomas also expressed LH beta, FSH beta and GnRH-R as well, indicating that these adenomas possessed gonadotrophic properties. Nine clinically non-functioning adenomas expressed Pit-1 as well as GH, PRL and/or TSH beta, thus having somatomammotrophic or thyrotrophic properties, 3 of which overlapped with the above DAX-1-expressing adenomas. One non-functioning adenoma expressed Ad4BP/SF1 and FSH beta but not DAX-1, and another one expressed DAX-1 and Ad4BP/SF-1 with PRL. On the other hand, all GH-secreting and PRL-secreting adenomas expressed Pit-1 and GH and/or PRL, but neither DAX-1 nor Ad4BP/SF-1.
The results shown here indicate that DAX-1 is expressed in the majority of human pituitary adenomas of gonadotrophic origin in parallel with Adrenal-4-binding protein/steroidogenic factor-1.
已知一种孤儿核受体DAX - 1参与垂体前叶细胞的发育和分化。本研究旨在探讨:1)DAX - 1是否在人垂体腺瘤中表达;2)若其表达,哪些类型的腺瘤表达该因子。
所检测的腺瘤组织包括18例临床无功能腺瘤、14例生长激素分泌型腺瘤和7例催乳素分泌型腺瘤。通过逆转录聚合酶链反应(RT - PCR)检测以下基因的表达:DAX - 1、肾上腺4结合蛋白/类固醇生成因子1(Ad4BP/SF - 1)、Pit - 1、促黄体生成素β亚基(LH beta)、促卵泡生成素β亚基(FSH beta)、促性腺激素释放激素受体(GnRH - R)、生长激素(GH)、催乳素(PRL)、促甲状腺激素β亚基(TSH beta),以及作为对照的β肌动蛋白。
11例临床无功能腺瘤表达DAX - 1,其中10例也表达Ad4BP/SF - 1。11例表达DAX - 1的腺瘤中有9例还表达LH beta、FSH beta和GnRH - R,表明这些腺瘤具有促性腺激素特性。9例临床无功能腺瘤表达Pit - 1以及GH、PRL和/或TSH beta,因此具有生长催乳素或促甲状腺激素特性,其中3例与上述表达DAX - 1的腺瘤重叠。1例无功能腺瘤表达Ad4BP/SF1和FSH beta但不表达DAX - 1,另1例表达DAX - 1和Ad4BP/SF - 1以及PRL。另一方面,所有生长激素分泌型和催乳素分泌型腺瘤均表达Pit - 1和GH及/或PRL,但不表达DAX - 1和Ad4BP/SF - 1。
此处所示结果表明,DAX - 1与肾上腺4结合蛋白/类固醇生成因子1同时在大多数促性腺激素起源的人垂体腺瘤中表达。